THE ‘SWALLOW TAIL’ SIGN ON MAGNETIC RESONANCE IMAGING 3-TESLA IN THE DIAGNOSIS OF PARKINSON DISEASE

Vĩnh Thành Nguyễn , Phương Trúc Võ , Công Chiến Phan , Ngọc Tài Trần

Main Article Content

Abstract

Background: Parkinson's disease is a common neurodegenerative disease but currently the diagnosis is mainly based on clinical criteria with certain accuracy. There are some imaging biomarkers that are being studied to increase diagnostic accuracy. Objective: To determine the sensitivity, specificity and predictive value of loss of the "swallow tail" sign on brain magnetic resonance imaging 3-Tesla in the diagnosis of Parkinson's disease. Methods: This is a case-control study with case group of 52 patients diagnosed with Parkinson's disease according to the criteria of the International Parkinson's Disease and Movement Disorder Society; and the control group included 35 people without any symptom of Parkinsonism. The “swallow tail” sign on brain MRI - 3T - SWI was evaluated independently and blinded in clinical by two neuroradiologists. The validity of the "swallow tail" sign in diagnosing Parkinson's disease was analyzed on SPSS 20.0. Reliability between two neuroradiologists was assessed based on Cohen's kappa index (κ). Significance level with p value <0.05. Results: Loss of the "swallow tail" sign unilaterally or bilaterally exists in all patients with Parkinson's disease and only in 2 cases (accounting for 5.71%) in the control group. The reliability between two neuroradiologists with Cohen's kappa index was 0.634 - 0.739. Loss of the "swallow tail" sign has a sensitivity and specificity of 94.34% and 91.67%, respectively. Conclusion: Loss of the "swallow tail" sign has high value in the diagnosis of Parkinson's disease and has the potential to become a new tool supporting in diagnosing Parkinson's disease.

Article Details

References

1. Connolly, B.S. and A.E. Lang, Pharmacological treatment of Parkinson disease: a review. Jama, 2014. 311(16): p. 1670-83.
2. Postuma, R.B., et al., MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord, 2015. 30(12): p. 1591-601.
3. Delenclos, M., et al., Biomarkers in Parkinson's disease: Advances and strategies. Parkinsonism Relat Disord, 2016. 22 Suppl 1: p. S106-10.
4. Schwarz, S.T., et al., The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T. PLoS One, 2014. 9(4): p. e93814.
5. Reiter, E., et al., Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism. Mov Disord, 2015. 30(8): p. 1068-76.
6. Mahlknecht, P., et al., Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease. Mov Disord, 2017. 32(4): p. 619-623.
7. Chau, M.T., et al., Diagnostic accuracy of the appearance of Nigrosome-1 on magnetic resonance imaging in Parkinson's disease: A systematic review and meta-analysis. Parkinsonism Relat Disord, 2020. 78: p. 12-20.
8. Kau, T., et al., Microvessels may Confound the "Swallow Tail Sign" in Normal Aged Midbrains: A Postmortem 7 T SW-MRI Study. J Neuroimaging, 2019. 29(1): p. 65-69.